The Valley Desk

ReviewCancerPublished

Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Review
Venue
Cancer
Published
Subject terms
Humans; Breast Neoplasms; Neoplasm Recurrence, Local; Aminopyridines; Piperazines; Benzimidazoles; Purines; Protein Kinase Inhibitors; Neoplasm Staging; Chemotherapy, Adjuvant; Risk Assessment; Female
PubMed ID
42667265
PubMed Central ID
PMC13525749
Added to directory
Source checked

Report a correction or request removal